Effect of maternal zinc supplementation on the cardiometabolic profile of Peruvian children: results from a randomized clinical trial.

What Was Tested

This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.

Zinc is an essential micronutrient for the development of the fetal renal, cardiovascular and metabolic systems; however, there is limited evidence of its effects on the postnatal cardiometabolic function.

In this study, the researchers evaluated the effect of maternal zinc supplementation during pregnancy on the cardiometabolic profile of the offspring in childhood.

Who Took Part

The study group was 242 women.

PubMed indexes the participants as children, young adults and adults, both men and women.

How the Study Was Run

In design terms this was a randomized and double-blind study.

Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

What Was Measured

In this study, the researchers evaluated the effect of maternal zinc supplementation during pregnancy on the cardiometabolic profile of the offspring in childhood.

Topics PubMed links to this paper include Cardiovascular Diseases, Dietary Supplements, Gestational Age, Maternal Nutritional Physiological Phenomena, Metabolic Syndrome, Peru and Zinc.

What This Means in Plain Language

The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc in 242 women.

The publication is from 2017 (Journal of developmental origins of health and disease), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.